Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection
Clinical trial NCT00001386 · COMPLETED
Trial details
- NCT number
- NCT00001386
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1994-06-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.